1 – 15 of 16
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
Comparison of Effect of Ischemic Postconditioning on Cardiovascular Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention With Versus Without Thrombectomy
(
- Contribution to journal › Article
- 2021
-
Mark
Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
- 2020
-
Mark
Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure
(
- Contribution to journal › Article
-
Mark
Sub-acute cardiac magnetic resonance to predict irreversible reduction in left ventricular ejection fraction after ST-segment elevation myocardial infarction : A DANAMI-3 sub-study
(
- Contribution to journal › Article
- 2019
-
Mark
Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI
(
- Contribution to journal › Article
-
Mark
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease : A DANAMI-3–PRIMULTI Cardiac Magnetic Resonance Substudy
(
- Contribution to journal › Article
- 2018
-
Mark
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI : A DANAMI-3 substudy
(
- Contribution to journal › Article
-
Mark
Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients
(
- Contribution to journal › Article
-
Mark
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
(
- Contribution to journal › Article
-
Mark
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients : A phase 2 randomised clinical trial
(
- Contribution to journal › Article
- 2016
-
Mark
Short and long-term survival after primary percutaneous coronary intervention in young patients with ST-elevation myocardial infarction.
(
- Contribution to journal › Article